Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
暂无分享,去创建一个
J. Cheville | R. Thompson | S. Boorjian | C. Lohse | B. Leibovich | B. Costello | C. Weight | Simon P. Kim | R. Thompson
[1] S. Boorjian,et al. Survival after complete surgical resection of multiple metastases from renal cell carcinoma , 2011, Cancer.
[2] P. Russo,et al. Clinical characteristics and outcomes of patients with recurrence 5 years after nephrectomy for localized renal cell carcinoma. , 2011, The Journal of urology.
[3] S. Horie,et al. Late recurrence of renal cell carcinoma: retrospective and collaborative study of the Japanese Society of Renal Cancer. , 2011, Urology.
[4] A. Jemal,et al. Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.
[5] J. Cheville,et al. Postoperative surveillance for renal cell carcinoma: a multifactorial histological subtype specific protocol , 2009, BJU international.
[6] Xin Huang,et al. Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] J. Patard,et al. Cancer‐specific and non‐cancer‐related mortality rates in European patients with T1a and T1b renal cell carcinoma , 2009, BJU international.
[8] S. Boorjian,et al. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses. , 2008, European urology.
[9] S. Boorjian,et al. Surgical resection of isolated retroperitoneal lymph node recurrence of renal cell carcinoma following nephrectomy. , 2008, The Journal of urology.
[10] M. Cooperberg,et al. Renal cell cancer stage migration , 2008, Cancer.
[11] B. Hollenbeck,et al. Five‐year survival after surgical treatment for kidney cancer , 2007, Cancer.
[12] J. Cheville,et al. Dynamic outcome prediction in patients with clear cell renal cell carcinoma treated with radical nephrectomy: the D-SSIGN score. , 2007, The Journal of urology.
[13] I. Gill,et al. The evolving presentation of renal carcinoma in the United States: trends from the Surveillance, Epidemiology, and End Results program. , 2006, The Journal of urology.
[14] Stephanie Daignault,et al. Rising Incidence of Small Renal Masses: A Need to Reassess Treatment Effect , 2006 .
[15] P. Russo,et al. Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] J. Lam,et al. Postoperative surveillance protocol for patients with localized and locally advanced renal cell carcinoma based on a validated prognostic nomogram and risk group stratification system. , 2005, The Journal of urology.
[17] Mythreyi Bhargavan,et al. Utilization of radiology services in the United States: levels and trends in modalities, regions, and populations. , 2005, Radiology.
[18] J. Cheville,et al. A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. , 2003, The Journal of urology.
[19] J. Cheville,et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma , 2003, Cancer.
[20] R. Figlin,et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] J. Cheville,et al. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. , 2002, The Journal of urology.
[22] R. Figlin,et al. Validation of the ucla integrated staging system for patients with renal cell carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] M. Kattan,et al. A postoperative prognostic nomogram for renal cell carcinoma. , 2001, The Journal of urology.
[24] R. Figlin,et al. Improved prognostication of renal cell carcinoma using an integrated staging system. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[25] M Mazumdar,et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] J L Warren,et al. Rising incidence of renal cell cancer in the United States. , 1999, JAMA.
[27] M Jayson,et al. Increased incidence of serendipitously discovered renal cell carcinoma. , 1998, Urology.
[28] York Springer,et al. Ajcc Cancer Staging Manual. 7th Ed. New , 2010 .
[29] M. Kattan,et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. , 2005, The Journal of urology.
[30] I. Frank,et al. Prediction of site-specific metastases in surgically treated nonmetastatic renal cell cancer , 2004 .
[31] C. Compton,et al. AJCC Cancer Staging Manual , 2002, Springer New York.